Skip to main content
Clinical Trials/ACTRN12614000872639
ACTRN12614000872639
Not yet recruiting
Not Applicable

A Randomised Control Trial of Eye Movement Desensitisation and Reprocessing (EMDR) for Post-Traumatic Stress Following Burn Injury

Royal North Shore Hospital0 sites40 target enrollmentAugust 14, 2014

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Post Traumatic Stress Disorder (PTSD)
Sponsor
Royal North Shore Hospital
Enrollment
40
Status
Not yet recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 14, 2014
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • All burns patients admitted to the Severe Burns Injury Unit at Royal Nortrh Shore Hospital, Sydney will be eligible to participate in the first (screening) phase of this study. Of these patients, those with moderate to high levels of uncomplicated post\-traumatic stress symptoms at 2\-4 weeks post injury will be offered participation in the second/treatment phase of this study. Moderate to high levels of post\-traumatic stress symptoms will be defined as an Impact of Event Scale Revised (IES\-R) score equal or greater than 26\.

Exclusion Criteria

  • 1\.Patients younger than 18 years of age.
  • 2\.Medical or psychiatric issue that impairs the ability of the participant to give informed consent.
  • 3\.Patients with high levels of dissociation (DES score \>40\)
  • 4\.Patients suffering from acute grief reactions
  • 5\.Patients at risk of self\-harm who cannot assure their safety.
  • 6\.Patients who remain in an unsafe environment/current abusive relationship.
  • 7\.Patients with complex chronic trauma histories that are unresolved (discernible signs of ongoing traumatic disorganization of reasoning, discourse and behaviour)
  • 8\.Patients that are required to give evidence or statements to the police or in a court of law.
  • 9\. Patients with self\-inflicted burns
  • Patients younger than 18 years of age and those with issues that impair the ability to give informed consent will be excluded as their capacity for informed consent will be affected.

Outcomes

Primary Outcomes

Not specified

Similar Trials